(0) items in cart / view cart / checkout  
 
  Chemicals
  Company Profiles
  Country Analyses
  Electronics
  Food & Beverage
  In Vitro Diagnostics
  Medical Devices
  Pharmaceuticals & Biotechnology
 
 
  Advertising
Aerospace, Defense
Automotive
Banking
Biotechnology
Business Services
Chemicals
Company Reports
Construction
Consumer Goods
Countries
Diagnostics
Energy, Environment
Food & Beverages
Government
Healthcare
IT
Manufacturing
Media
Medical Devices
Pharmaceuticals
Retailing
Sales & Marketing
Sourcing
Telecommunications
Transportation
Travel, Entertainment
 
Home > Pharmaceuticals & Biotechnology
 
 
Animal Health - 129
Biotechnology - 35
Ethical Pharmaceuticals - 143
Healthcare - 14
Medical Equipment - 58
Pharmaceutical Intermediates - 10
 
 Pharmaceuticals & Biotechnology Market Research Reports
Title

To order sections of the reports, contact Client Services.

Price
« Previous  1  2  3  4  5  6  7  8  9  10  Next »
Research Report on China's Veterinary Active Pharmaceutical Ingredient and Chemical Preparation Industry

On the basis of an exposition about the status quo of China's veterinary active pharmaceutical ingredients and chemical preparations industry in 2011, the report will make an in-depth analysis of the development environment, enterprises structure and scale, as well as the circulation and marketing of China's veterinary chemicals industry. Besides, the report will also make a detailed and objective analysis of the development trend of China's veterinary chemicals industry, aiming to be of help to the scientific judgment of the investment value of China's veterinary chemicals industry.

 

$6000.00
       
Competitive Analysis of the Global Opioid Therapeutics Market

This research service focuses on the current status of candidates for opioid therapeutics with a focus on current Phase 3 candidates, detailed timelines, rational for pivotal program design, Phase 2 data review and key opinion leader (KOL) commentary. A pipeline assessment is provided for all active candidates in development....

 

$6000.00
       
OpportunityAnalyzer: Cystic Fibrosis Therapeutics - Opportunity Analysis and Forecasts to 2017

Summary

Cystic Fibrosis (CF) is an autosomal recessive disease characterized by the secretion of thick, sticky mucus which clogs the lungs and leads to life-threatening lung infections; and obstructs pancreatic enzyme secretions that are essential for the body to break down and absorb nutrients. CF patients have a limited number of available treatment options and significant unmet needs still exist....

 

$5995.00
       
OpportunityAnalyzer: Idiopathic Pulmonary Fibrosis (IPF) - Opportunity Analysis and Forecasts to 2017

Summary

Idiopathic Pulmonary fibrosis (IPF) is a chronic, progressive fibrosing interstitial pneumonia of unknown cause. Limited to the lungs it occurs primarily in older adults’ =50 years old, with an abysmal prognosis (3-5 years following diagnosis)....

 

$5995.00
       
Pharmaceutical Leaders 2012 - Key Trends, Emerging Strategies and Financial Analysis of the Top Performers

“Pharmaceutical Leaders 2012 - Key Trends, Emerging Strategies and Financial Analysis of the Top Performers” Report integrates deep research of top players in the pharmaceutical industry with our proprietary analysis and ranking methodology to reveal top performers, industry trends, and the strategies that successful companies are using to stay ahead in the increasingly demanding pharmaceutical marketplace. Clients can use this report for strategic planning and tracking of competitor strategies....

 

$5700.00
       
Peptides in Oncology Drug Pipeline Update 2013

There are today 227 companies plus partners developing 203 peptide drugs in 465 developmental projects in cancer. In addition, there are 5 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 122 drugs....

 

$5621.25
       
Lung Cancer Drug Pipeline Update 2013

Non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) comprises over 95% of all lung cancers. High unmet needs still persist for this tumor type and despite two decades of extensive R&D and chemotherapy use, the median overall survival of NSCLC patient’s remains below 12 months....

 

$5621.25
       
French Blood Banking Market

This report presents a comprehensive analysis of the French blood banking market, including:
  • Major issues pertaining to the French blood banking practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
  • Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in French blood banks hospitals, and commercial laboratories....

 

$5400.00
       
German Blood Banking Market

This report presents a comprehensive analysis of the German blood banking market, including:
  • Major issues pertaining to the German blood banking practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
  • Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in German blood banks, hospitals and commercial laboratories....

 

$5400.00
       
Italian Blood Banking Market

This report presents a comprehensive analysis of the Italian blood banking market, including:
  • Major issues pertaining to the Italian blood banking practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
  • Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in Italian blood banks hospitals, and commercial laboratories....

 

$5400.00
       
Spanish Blood Banking Market

This report presents a comprehensive analysis of the Spanish blood banking market, including:
  • Major issues pertaining to the Spanish blood banking practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
  • Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in Spanish blood banks hospitals and commercial laboratories....

 

$5400.00
       
UK Blood Banking Market

This report presents a comprehensive analysis of the UK blood banking market, including:

  • Major issues pertaining to the UK blood banking practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
  • Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in UK blood banks hospitals and commercial laboratories....

 

$5400.00
       
French Cancer Diagnostics Market

This report presents a comprehensive analysis of the French cancer diagnostics market, including:
  • Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
  • Mortality statistics and scientific views on the etiology of major types of cancer, e....

 

$5400.00
       
German Cancer Diagnostics Market

This report presents a comprehensive analysis of the German cancer diagnostics market, including:
  • Major issues pertaining to the German laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
  • Mortality statistics and scientific views on the etiology of major types of cancer, e....

 

$5400.00
       
Italian Cancer Diagnostics Market

This report presents a comprehensive analysis of the Italian cancer diagnostics market, including:
  • Major issues pertaining to the Italian laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
  • Mortality statistics and scientific views on the etiology of major types of cancer, e....

 

$5400.00
       
Spanish Cancer Diagnostics Market

This report presents a comprehensive analysis of the Spanish cancer diagnostics market, including:
  • Major issues pertaining to the Spanish laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
  • Mortality statistics and scientific views on the etiology of major types of cancer, e....

 

$5400.00
       
UK Cancer Diagnostics Market

This report presents a comprehensive analysis of the UK cancer diagnostics market, including:
  • Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
  • Mortality statistics and scientific views on the etiology of major types of cancer, e....

 

$5400.00
       
Discovery, Preclinical and Clinical Stage Partnering Terms and Agreements in Pharma and Biotech

The Discovery, Preclinical and Clinical Stage Partnering Terms and Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the discovery, preclinical and clinical stage partnering deals and agreements entered into by the worlds leading healthcare companies.

 

$4995.00
       
« Previous     1  2  3  4  5  6  7  8  9  10   Next »
 
VPGMarketResearch.com © Copyright 2015. all rights reserved. Web Design by Spida Design  
  Close  X